Danimer Scientific, Inc. (‘Danimer’ or the ‘Company’) announced that it has signed a definitive agreement to acquire Novomer, Inc. (‘Novomer’), in a cash transaction valued at $152 million. Each company’s Board of Directors has approved the transaction. Novomer’s Chief Executive Officer, Jeff Uhrig, will report to Danimer CEO Stephen E. Croskrey and will continue to lead the Novomer team in coordination with Danimer’s senior leadership.